IL162267A0 - Pharmaceutical formulation for the active ingredient budesonide - Google Patents
Pharmaceutical formulation for the active ingredient budesonideInfo
- Publication number
- IL162267A0 IL162267A0 IL16226703A IL16226703A IL162267A0 IL 162267 A0 IL162267 A0 IL 162267A0 IL 16226703 A IL16226703 A IL 16226703A IL 16226703 A IL16226703 A IL 16226703A IL 162267 A0 IL162267 A0 IL 162267A0
- Authority
- IL
- Israel
- Prior art keywords
- active ingredient
- pharmaceutical formulation
- layer
- binding agent
- bound
- Prior art date
Links
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 title abstract 2
- 229960004436 budesonide Drugs 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000011230 binding agent Substances 0.000 abstract 2
- 238000009472 formulation Methods 0.000 abstract 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 229920000642 polymer Polymers 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229920001577 copolymer Polymers 0.000 abstract 1
- 238000004090 dissolution Methods 0.000 abstract 1
- 230000000968 intestinal effect Effects 0.000 abstract 1
- 239000008363 phosphate buffer Substances 0.000 abstract 1
- 210000002784 stomach Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10214002A DE10214002A1 (de) | 2002-03-27 | 2002-03-27 | Pharmazeutische Formulierung für den Wirkstoff Budesonid |
| PCT/EP2003/002269 WO2003080032A2 (fr) | 2002-03-27 | 2003-03-06 | Formulation pharmaceutique pour le principe actif budesonide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL162267A0 true IL162267A0 (en) | 2005-11-20 |
Family
ID=27816040
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16226703A IL162267A0 (en) | 2002-03-27 | 2003-03-06 | Pharmaceutical formulation for the active ingredient budesonide |
| IL162267A IL162267A (en) | 2002-03-27 | 2004-06-01 | Pharmaceutical formulation for the active ingredient budesonide |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL162267A IL162267A (en) | 2002-03-27 | 2004-06-01 | Pharmaceutical formulation for the active ingredient budesonide |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20050089571A1 (fr) |
| EP (1) | EP1487421B1 (fr) |
| JP (1) | JP4488171B2 (fr) |
| KR (1) | KR101200286B1 (fr) |
| AT (1) | ATE316784T1 (fr) |
| AU (1) | AU2003212306A1 (fr) |
| BR (1) | BR0308761A (fr) |
| CA (1) | CA2478506C (fr) |
| DE (2) | DE10214002A1 (fr) |
| ES (1) | ES2256722T3 (fr) |
| IL (2) | IL162267A0 (fr) |
| MX (1) | MXPA04009378A (fr) |
| PL (1) | PL206241B1 (fr) |
| WO (1) | WO2003080032A2 (fr) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10220470A1 (de) * | 2002-04-30 | 2003-11-20 | Roehm Gmbh | ph-sensitives Polymer |
| US8895064B2 (en) | 1999-06-14 | 2014-11-25 | Cosmo Technologies Limited | Controlled release and taste masking oral pharmaceutical composition |
| CN1173695C (zh) | 1999-06-14 | 2004-11-03 | 科斯默股份公司 | 控制释放与掩蔽味道的口服药物组合物 |
| DE10011447A1 (de) * | 2000-03-10 | 2001-09-20 | Roehm Gmbh | Dispersion mit nichtionischem Emulgator |
| US7979127B2 (en) * | 2001-05-01 | 2011-07-12 | Intrapace, Inc. | Digestive organ retention device |
| US7616996B2 (en) * | 2005-09-01 | 2009-11-10 | Intrapace, Inc. | Randomized stimulation of a gastrointestinal organ |
| US6535764B2 (en) * | 2001-05-01 | 2003-03-18 | Intrapace, Inc. | Gastric treatment and diagnosis device and method |
| DE10208335A1 (de) * | 2002-02-27 | 2003-09-04 | Roehm Gmbh | Arzneiform und Verfahren zu ihrer Herstellung |
| MXPA04010956A (es) * | 2003-01-30 | 2005-01-25 | Roehm Gmbh | Forma de dosis farmaceutica y metodo para la produccion de la misma. |
| AU2004271743B2 (en) * | 2003-09-15 | 2010-06-10 | Covis Pharma B.V. | Use of ciclesonide for the treatment of inflammatory bowel diseases |
| GB0403247D0 (en) * | 2004-02-13 | 2004-03-17 | Tillotts Pharma Ag | A pharmaceutical composition |
| DE102004035936A1 (de) * | 2004-07-23 | 2006-03-16 | Röhm GmbH & Co. KG | Mehrschichtige Arzneiform |
| BRPI0610683B8 (pt) | 2005-05-18 | 2021-05-25 | Hopitaux Paris Assist Publique | aplicação colônica de absorventes |
| US7509175B2 (en) | 2006-08-03 | 2009-03-24 | Intrapace, Inc. | Method and devices for stimulation of an organ with the use of a transectionally placed guide wire |
| US8048413B2 (en) | 2006-05-17 | 2011-11-01 | Helene Huguet | Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules |
| JP5257070B2 (ja) | 2006-06-13 | 2013-08-07 | 日本新薬株式会社 | 被覆錠剤 |
| ES2311373B1 (es) * | 2006-09-27 | 2009-12-21 | Dmc Research Center, S.L. | "utilizacion de un compuesto antibacteriano derivado de alliaceas, como aditivos en alimentacion animal". |
| AU2008230364A1 (en) * | 2007-03-26 | 2008-10-02 | Teikoku Seiyaku Co., Ltd. | Oral pharmaceutical preparation for colon-specific delivery |
| US9217024B2 (en) | 2007-12-18 | 2015-12-22 | Acumen Pharmaceuticals, Inc. | ADDL receptor polypeptides, polynucleotides and host cells for recombinant production |
| JP4864024B2 (ja) * | 2008-02-15 | 2012-01-25 | エスエス製薬株式会社 | 時限放出製剤 |
| GB0808537D0 (en) * | 2008-05-12 | 2008-06-18 | Archimedes Dev Ltd | Compositions |
| DE102008048729A1 (de) * | 2008-09-24 | 2010-03-25 | Add Technologies Ltd Advanced Drug Delivery | Multipartikuläre Tabletten und Verfahren zur deren Herstellung |
| US8945615B2 (en) * | 2009-02-17 | 2015-02-03 | Mylan Pharmaceuticals Inc. | Controlled release budesonide minitablets |
| US8945616B2 (en) * | 2009-02-17 | 2015-02-03 | Mylan Pharmaceuticals Inc. | Controlled release budesonide minitablets |
| US10154964B2 (en) | 2011-09-07 | 2018-12-18 | Cosmo Technologies Limited | Controlled release and taste masking oral pharmaceutical composition |
| IN2014CH01890A (fr) * | 2014-04-10 | 2015-10-16 | Aurobindo Pharma Ltd | |
| CA2936746C (fr) | 2014-10-31 | 2017-06-27 | Purdue Pharma | Methodes et compositions destinees au traitement du trouble de deficit d'attention |
| PL3302444T3 (pl) | 2015-06-05 | 2021-03-22 | Evonik Operations Gmbh | Kompozycja farmaceutyczna lub odżywcza odporna na działanie etanolu |
| RU2018111690A (ru) | 2015-09-11 | 2019-10-11 | Сан Фармасьютикл Индастриз Лтд. | Пероральная лекарственная форма будесонида |
| EP3613414A1 (fr) | 2018-08-24 | 2020-02-26 | Dr. Falk Pharma Gmbh | Granulés à structure multicouche permettant la libération retardée de la substance active dans le colon distal |
| US10722473B2 (en) | 2018-11-19 | 2020-07-28 | Purdue Pharma L.P. | Methods and compositions particularly for treatment of attention deficit disorder |
| EP4327806A4 (fr) * | 2021-04-20 | 2024-10-23 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Capsule pour administration de médicament spécifique et son procédé de préparation |
| US11896719B2 (en) | 2022-01-24 | 2024-02-13 | Calliditas Therapeutics Ab | Pharmaceutical compositions |
| US12303604B1 (en) | 2024-10-16 | 2025-05-20 | Currax Pharmaceuticals Llc | Pharmaceutical formulations comprising naltrexone and/or bupropion |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5643602A (en) * | 1989-11-22 | 1997-07-01 | Astra Aktiebolag | Oral composition for the treatment of inflammatory bowel disease |
| US5260068A (en) * | 1992-05-04 | 1993-11-09 | Anda Sr Pharmaceuticals Inc. | Multiparticulate pulsatile drug delivery system |
| DE4332394A1 (de) * | 1993-09-23 | 1995-03-30 | Falk Pharma Gmbh | Budesonid-Pellets mit kontrolliertem Freigabeprofil und Verfahren zu ihrer Herstellung |
| DE4402666A1 (de) * | 1994-01-29 | 1995-08-03 | Roehm Gmbh | Verfahren zum kurzzeitigen Behandeln einer Kunststoffschmelze mit einem flüssigen Behandlungsmittel und dabei hergestellter thermoplastischer Kunststoff |
| DE9414066U1 (de) * | 1994-08-31 | 1994-11-03 | Röhm GmbH & Co. KG, 64293 Darmstadt | Überzugs- und Bindemittel für Arzneiformen sowie damit hergestellte Arzneiform |
| DE9414065U1 (de) * | 1994-08-31 | 1994-11-03 | Röhm GmbH & Co. KG, 64293 Darmstadt | Thermoplastischer Kunststoff für darmsaftlösliche Arznei-Umhüllungen |
| DE19544562B4 (de) * | 1995-11-30 | 2004-05-27 | Röhm GmbH & Co. KG | Verfahren zur Herstellung von Poly(meth)acrylimiden mit bei thermischer Belastung verbesserter Farbstabilität und daraus erhältliche Formkörper |
| DE19718597C1 (de) * | 1997-05-02 | 1999-01-07 | Roehm Gmbh | Zweistufiges Verfahren zur Entwässerung von Kunststoffdispersionen |
| MXPA01002779A (es) * | 1998-09-18 | 2002-04-08 | Roehm Gmbh | Herramienta de moldeo para piezas brutas de discos portadores de informacion. |
| DE10220470A1 (de) * | 2002-04-30 | 2003-11-20 | Roehm Gmbh | ph-sensitives Polymer |
| DE10011447A1 (de) * | 2000-03-10 | 2001-09-20 | Roehm Gmbh | Dispersion mit nichtionischem Emulgator |
| DE10013029A1 (de) * | 2000-03-17 | 2001-09-20 | Roehm Gmbh | Mehrschichtige Arzneiform für die Colonfreigabe |
| DE10065492A1 (de) * | 2000-12-28 | 2003-06-26 | Roehm Gmbh | Diffus ausgestattete Formmassen und hieraus erhältliche Formkörper |
| ATE380022T1 (de) * | 2001-01-31 | 2007-12-15 | Evonik Roehm Gmbh | Multipartikuläre arzneiform, enthaltend mindestens zwei unterschiedlich überzogene pelletformen |
| DE10208335A1 (de) * | 2002-02-27 | 2003-09-04 | Roehm Gmbh | Arzneiform und Verfahren zu ihrer Herstellung |
-
2002
- 2002-03-27 DE DE10214002A patent/DE10214002A1/de not_active Withdrawn
-
2003
- 2003-03-06 BR BR0308761-1A patent/BR0308761A/pt not_active IP Right Cessation
- 2003-03-06 DE DE50302336T patent/DE50302336D1/de not_active Expired - Lifetime
- 2003-03-06 IL IL16226703A patent/IL162267A0/xx unknown
- 2003-03-06 ES ES03708180T patent/ES2256722T3/es not_active Expired - Lifetime
- 2003-03-06 MX MXPA04009378A patent/MXPA04009378A/es active IP Right Grant
- 2003-03-06 AU AU2003212306A patent/AU2003212306A1/en not_active Abandoned
- 2003-03-06 PL PL371121A patent/PL206241B1/pl not_active IP Right Cessation
- 2003-03-06 JP JP2003577862A patent/JP4488171B2/ja not_active Expired - Fee Related
- 2003-03-06 AT AT03708180T patent/ATE316784T1/de active
- 2003-03-06 WO PCT/EP2003/002269 patent/WO2003080032A2/fr not_active Ceased
- 2003-03-06 KR KR1020047015369A patent/KR101200286B1/ko not_active Expired - Fee Related
- 2003-03-06 EP EP03708180A patent/EP1487421B1/fr not_active Expired - Lifetime
- 2003-03-06 US US10/501,236 patent/US20050089571A1/en not_active Abandoned
- 2003-03-06 CA CA002478506A patent/CA2478506C/fr not_active Expired - Fee Related
-
2004
- 2004-06-01 IL IL162267A patent/IL162267A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PL206241B1 (pl) | 2010-07-30 |
| KR20040102060A (ko) | 2004-12-03 |
| JP2005521696A (ja) | 2005-07-21 |
| US20050089571A1 (en) | 2005-04-28 |
| PL371121A1 (en) | 2005-06-13 |
| ATE316784T1 (de) | 2006-02-15 |
| JP4488171B2 (ja) | 2010-06-23 |
| WO2003080032A2 (fr) | 2003-10-02 |
| DE50302336D1 (de) | 2006-04-13 |
| AU2003212306A1 (en) | 2003-10-08 |
| BR0308761A (pt) | 2005-01-11 |
| CA2478506C (fr) | 2009-09-08 |
| WO2003080032A3 (fr) | 2004-01-08 |
| KR101200286B1 (ko) | 2012-11-13 |
| ES2256722T3 (es) | 2006-07-16 |
| MXPA04009378A (es) | 2005-01-25 |
| IL162267A (en) | 2010-02-17 |
| CA2478506A1 (fr) | 2003-10-02 |
| EP1487421A2 (fr) | 2004-12-22 |
| DE10214002A1 (de) | 2003-10-09 |
| EP1487421B1 (fr) | 2006-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL162267A (en) | Pharmaceutical formulation for the active ingredient budesonide | |
| AU2001255509B2 (en) | Taste masking coating composition | |
| JP4979180B2 (ja) | 薬学的に活性な薬剤の浸透送達のためのシステム | |
| US11324721B2 (en) | Secnidazole for use in the treatment of trichomoniasis | |
| MX9500885A (es) | Preparacion farmaceutica para administracion oral. | |
| WO2006044202A3 (fr) | Compositions a revetement enterique qui liberent un/des principe(s) actif(s) dans les liquides gastro-intestinaux | |
| AU2001255509A1 (en) | Taste masking coating composition | |
| AU3345197A (en) | Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof | |
| CN105163743A (zh) | 用于治疗幽门螺杆菌的药物组合物 | |
| US20070099843A1 (en) | Nutritional supplement for the enhancement of the health of the liver | |
| CA2905467C (fr) | Composition pharmaceutique de mesalamine avec elements de dose multiples pour variabilite d'administration reduite | |
| Nagaveni et al. | A Complete Review on Mucoadhesive Buccal Tablets | |
| AU705570B2 (en) | Microgranules of 5-nitro imidazole derivatives | |
| RU96117257A (ru) | Галеновая форма производных 5-нитроимидазола | |
| JPS6115829A (ja) | 口腔粘膜適用徐放性ニフエジピン製剤 | |
| JP2014189547A (ja) | 嚥下物被覆体 | |
| WO2007062262A3 (fr) | Preparation medicamenteuse gelatineuse et methode d'administration |